awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38207012-AA9AB825-C7E9-4022-8738-BC4C615635FA
Q38207012-AA9AB825-C7E9-4022-8738-BC4C615635FA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38207012-AA9AB825-C7E9-4022-8738-BC4C615635FA
Hepatocellular carcinoma review: current treatment, and evidence-based medicine.
P2860
Q38207012-AA9AB825-C7E9-4022-8738-BC4C615635FA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38207012-AA9AB825-C7E9-4022-8738-BC4C615635FA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
599bbc4279e1ad33ff943ea3ccde33e0db71a2cc
P2860
Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma.